Inventor · disambiguated record
Patricia Hurter
Also filed as: HURTER PATRICIA · HURTER PATRICIA NELL
16 granted patents·16 pending applications·549 citations·filing 2005–2024
95Inventor score
Top patents by PatentIndex Score
32 records- 0198US9670163B2Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamideVERTEX PHARMA·Filed 2015·Granted Jun 6, 2017·44 cites·8 claims
- 0298US9139530B2Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamideVERTEX PHARMA·Filed 2014·Granted Sep 22, 2015·64 cites·28 claims
- 0398US8754224B2Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamideVERTEX PHARMA·Filed 2013·Granted Jun 17, 2014·97 cites·18 claims
- 0497US10646481B2Pharmaceutical composition and administrations thereofVERTEX PHARMA·Filed 2016·Granted May 12, 2020·21 cites·26 claims
- 0597US10537565B2Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamideVERTEX PHARMA·Filed 2018·Granted Jan 21, 2020·24 cites·26 claims
- 0697US9931334B2Solid forms of N[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamideVERTEX PHARMA·Filed 2017·Granted Apr 3, 2018·35 cites·17 claims
- 0796US11564916B2Pharmaceutical composition and administrations thereofVERTEX PHARMA·Filed 2020·Granted Jan 31, 2023·7 cites·40 claims
- 0896US8883206B2Pharmaceutical composition and administrations thereofVERTEX PHARMA·Filed 2014·Granted Nov 11, 2014·83 cites·10 claims
- 0996US8410274B2Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamideHURTER PATRICIA·Filed 2012·Granted Apr 2, 2013·109 cites·22 claims
- 1095US10272046B2Pharmaceutical composition and administrations thereofVERTEX PHARMA·Filed 2016·Granted Apr 30, 2019·27 cites·23 claims
- 1194US11752106B2Pharmaceutical composition and administrations thereofVERTEX PHARMA·Filed 2021·Granted Sep 12, 2023·3 cites·20 claims
- 1293US11147770B2Pharmaceutical composition and administrations thereofVERTEX PHARMA·Filed 2019·Granted Oct 19, 2021·6 cites·22 claims
- 1392US11291662B2Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamideVERTEX PHARMA·Filed 2019·Granted Apr 5, 2022·5 cites·4 claims
- 1489US2025255819A1Pharmaceutical composition and administrations thereofVERTEX PHARMA·Filed 2024·Application pending·0 cites
- 1587US10231932B2Process of preparing pharmaceutical compositions for the treatment of CFTR mediated diseasesVERTEX PHARMA·Filed 2014·Granted Mar 19, 2019·24 cites·8 claims
- 1686US12214083B2Pharmaceutical composition and administrations thereofVERTEX PHARMA·Filed 2023·Granted Feb 4, 2025·0 cites·20 claims
- 1784US2023263794A1Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamideVERTEX PHARMA·Filed 2022·Application pending·0 cites
- 1866US2010074949A1Pharmaceutical composition and administration thereofROWE WILLIAM·Filed 2009·Application pending·0 cites
- 1965US12458635B2Pharmaceutical composition and administrations thereofVERTEX PHARMA·Filed 2022·Granted Nov 4, 2025·0 cites·17 claims
- 2065US2015024047A1Pharmaceutical composition and administrations thereofVERTEX PHARMA·Filed 2014·Application pending·0 cites
- 2161US2011064811A1Solid forms of N-[2,4-BIS(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamideHURTER PATRICIA·Filed 2006·Application pending·0 cites
- 2261US2013224293A1Pharmaceutical composition and administrations thereofVERTEX PHARMA·Filed 2013·Application pending·0 cites
- 2359US2014112988A1Pharmaceutical Composition and Administrations ThereofVERTEX PHARMA·Filed 2013·Application pending·0 cites
- 2457US2014315948A1Pharmaceutical Composition and Administrations ThereofVERTEX PHARMA·Filed 2014·Application pending·0 cites
- 2557US2015246031A1Pharmaceutical composition and administrations thereofVERTEX PHARMA·Filed 2015·Application pending·0 cites
- 2652US2012258983A1Pharmaceutical Composition and Administrations ThereofROWE WILLIAM·Filed 2012·Application pending·0 cites
- 2751US2008070972A1Controlled release formulationsKADIYALA IRINA N·Filed 2007·Application pending·0 cites
- 2848US2013274180A1Pharmaceutical CompositionsVERTEX PHARMA·Filed 2013·Application pending·0 cites
- 2947US2010256184A1Pharmaceutical composition and administrations thereofVERTEX PHARMA·Filed 2010·Application pending·0 cites
- 3044US2006089385A1Pharmaceutical compositionsCUI YONG·Filed 2005·Application pending·0 cites
- 3142US2011021598A1Controlled release formulationsVERTEX PHARMA·Filed 2010·Application pending·0 cites
- 3239US2012220625A1Pharmaceutical composition and administrations thereofROWE WILLIAM·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Patricia Hurter files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →